![The sights of Paris Air Show, one last time: Day 4 [Photos]](https://breakingdefense.com/wp-content/uploads/sites/3/2025/06/20250617-helenedelacoste-Paris-Air-Show-037-scaled-e1750357690820.jpg?#)
FDA’s gene therapy turmoil, and an alternative model for funding research
Why did the Food and Drug Administration suddenly oust one of its top gene therapy regulators?
Why did the Food and Drug Administration suddenly oust one of its top gene therapy regulators? Is the agency growing too political? And should private firms fund academic research?
We chat about all that and more on this on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. We discuss the tragic news that a second teenage boy with Duchenne muscular dystrophy died after taking Sarepta Therapeutics’ gene therapy, raising renewed questions about the FDA’s standards for approving drugs.
